Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Accenture
Daiichi Sankyo
Moodys
Express Scripts
US Army
Julphar
AstraZeneca
Dow

Generated: April 20, 2018

DrugPatentWatch Database Preview

LINCOMYCIN HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Lincomycin Hydrochloride patents expire, and what generic alternatives are available?

Lincomycin Hydrochloride is a drug marketed by Watson Labs and is included in one NDA.

The generic ingredient in LINCOMYCIN HYDROCHLORIDE is lincomycin hydrochloride. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the lincomycin hydrochloride profile page.
Drug patent expirations by year for LINCOMYCIN HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for LINCOMYCIN HYDROCHLORIDE
Synonyms for LINCOMYCIN HYDROCHLORIDE
(2S,4R)-N-((1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide
(2S,4R)-N-((1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride
(2S,4R)-N-((1S)-2-hydroxy-1-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide hydrochloride
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide hydrate hydrochloride
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrate;hydrochloride
(2S,4R)-N-{(1S)-2-hydroxy-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-tetrahydro-2H-2-pyranyl]propyl}-1-methyl-4-propylpyrrolidine-2-carboxamide Hydrochloride
1-Methyl-4-propyl-pyrrolidine-2-carboxylic acid [2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyl-tetrahydro-pyran-2-yl)-propyl]-amide
12768-69-3
154-21-2
154-21-2 (Parent)
16977-76-7
17431-82-2
179L499
2516AH
3QB
54L212
59112-35-5
7179-49-9
7179-49-9 (mono-hydrochloride, hemi.hydrate)
8000-45-1
859-18-7
859-18-7 (mono-hydrochloride)
859L187
A-7633
AB01275426-01
AB1009493
AC1L21SE
AC1L2G8D
AC1MHD7X
AC1Q3E14
AK163544
AK481281
AKOS015896677
AKOS015951392
AKOS024375415
Ambap7179-49-9
AN-15758
AN-20542
Antibiotic 124a, hydrochloride
ANW-42016
API0007268
AS-13720
AX8136368
BB_NC-1334
BDBM50335522
BOD072YW0F
BRD-K49384696-003-01-9
BRN 0707677
C-22393
C06812
C14002
C18H34N2O6S
C18H34N2O6S.ClH.H2O
C18H34N2O6S.HCl
C18H37ClN2O7S
CAS-859-18-7
CCG-208231
CCG-220302
CCRIS 9080
CHEBI:6472
CHEMBL1201097
CHEMBL1447
Cillimycin
CS-2521
CS-4856
CTK8B3221
D-Erythro-.alpha.-D-gluco-octopyranoside, methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-
D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-((((2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-
D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-((((2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, monohydrochloride
D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, (2S-trans)-
D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, monohydrochloride, (2S-trans)- (9CI)
D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, monohydrochloride, monohydrate, (2S-trans)-
D-erythro-D-galacto-Octapyranoside, methyl 6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, monohydrochloride, monohydrate, trans-alpha-
D-erythro-D-Galacto-octopyranoside, methyl 6,8-dideoxy-6-(1-methyl-4-propyl-2-pyrrolidinecarboxamido)-1-thio-, monohydrochloride, hemihydrate
D-erythro-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, monohydrochloride, trans-alpha-
D-erythro-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, trans-alpha-
D00223
D02346
DB01627
DSSTox_CID_27780
DSSTox_GSID_47803
DSSTox_RID_82556
DTXSID3023215
DTXSID7047803
EC 212-726-7
EINECS 205-824-6
EINECS 212-726-7
Frademicina
FT-0630364
FT-0696547
GCW8Y9936L
HMS2089A13
HSDB 3109
HY-B0417A
HY-B1358
I06-2232
J10175
Jiemycin
L0166
LFZGYTBWUHCAKF-DCNJEFSFSA-N
Lincocin
Lincocin (TN)
Lincocin Hydrochloride
Lincogap
Lincolcina
Lincolnensin
Lincolnensin, hydrochloride
Lincomicina
Lincomicina [INN-Spanish]
Lincomix
Lincomix 20
lincomycin
Lincomycin (hydrochloride hydrate)
Lincomycin (hydrochloride)
Lincomycin (USAN/INN)
Lincomycin [USAN:INN:BAN]
Lincomycin A
LINCOMYCIN HCL
Lincomycin HCl (Lincocin)
Lincomycin hydrochloride [USAN:JAN]
Lincomycin hydrochloride anhydrous
Lincomycin hydrochloride for system suitability, European Pharmacopoeia (EP) Reference Standard
Lincomycin hydrochloride hydrate
Lincomycin hydrochloride hydrate (JP17/USP)
Lincomycin hydrochloride monohydrate
Lincomycin hydrochloride monohydrate, VETRANAL(TM), analytical standard
Lincomycin hydrochloride, >=90% (TLC)
Lincomycin hydrochloride, >=95.0% (TLC)
Lincomycin hydrochloride, BioReagent, suitable for cell culture
Lincomycin hydrochloride, European Pharmacopoeia (EP) Reference Standard
Lincomycin hydrochloride, monohydrate
Lincomycin Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur
Lincomycin hydrochloride, United States Pharmacopeia (USP) Reference Standard
Lincomycin Monohydrochloride, Hemihydrate
Lincomycin soluble
Lincomycin, (2S-cis)-Isomer
Lincomycin, Antibiotic for Culture Media Use Only
Lincomycin, hydrochloride hydrate
Lincomycine
Lincomycine [French]
Lincomycine [INN-French]
Lincomycinum
Lincomycinum [INN-Latin]
LS-174366
LS-174532
LS-98138
M6T05Z2B68
MCULE-4676929559
medoglycine
Methyl (2S-trans)-6,8-dideoxy-6-(((1-methyl-4-propylpyrrolidin-2-yl)carbonyl)amino)-1-thio-D-erythro-alpha-D-galacto-octopyranoside monohydrochloride
methyl 6,8-dideoxy-6-({[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]carbonyl}amino)-1-thio-D-erythro-alpha-D-galacto-octopyranoside
Methyl 6,8-dideoxy-6-(1-methyl-4-propyl-2-pyrrolidinecarboxamido)-1-thio-D-erythro-|A-D-galactooctopyranoside hydrochloride
Methyl 6,8-dideoxy-6-(1-methyl-4-propyl-2-pyrrolidinecarboxamido)-1-thio-D-erythro-D-galacto-octopyranoside (alpha-form)
Methyl 6,8-dideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-D-erythro-alpha-D-galacto-octopyranoside monohydrochloride monohydrate
Methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-D-erythro-|A-D-glucooctopyranoside
methyl 6,8-dideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-D-erythro-alpha-D-galacto-octopyranoside
Methyl 6,8-dideoxy-6-trans-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-D-erythro-alpha-D-galacto-octopyranoside
MFCD00083647
MFCD00167245
MolPort-002-507-379
MolPort-003-983-295
MolPort-009-653-451
Mycivin
N-[(1R,2R)-1-((4S,2R,3R,5R,6R)-3,4,5-trihydroxy-6-methylthio(2H-3,4,5,6-tetrah ydropyran-2-yl))-2-hydroxypropyl]((2S,4R)-1-methyl-4-propylpyrrolidin-2-yl)car boxamide, chloride
NCGC00159326-02
NCGC00159326-03
NE39438
NSC 70731
NSC-70731
NSC70731
OJMMVQQUTAEWLP-KIDUDLJLSA-N
POUMFISTNHIPTI-BOMBIWCESA-N
Pura Ject 100
SC-71087
SCHEMBL192963
SCHEMBL192964
SCHEMBL4010
SMP1_000178
ST51016093
STOCK1N-50613
SureCN721610
Tox21_111575
Tox21_111575_1
TR-031563
U 10,149A
U 10149a
U-10,149
U-10149
UNII-BOD072YW0F
UNII-GCW8Y9936L
UNII-M6T05Z2B68
W-109518
Z1665194511
ZINC3982483

US Patents and Regulatory Information for LINCOMYCIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs LINCOMYCIN HYDROCHLORIDE lincomycin hydrochloride INJECTABLE;INJECTION 063180-001 Apr 16, 1991 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Queensland Health
Citi
Johnson and Johnson
Julphar
Farmers Insurance
Harvard Business School
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.